Thanks for the correction .I inadvertently expande
Post# of 72440
(Total Views: 724)
Posted On: 03/17/2021 9:30:31 PM
Thanks for the correction .I inadvertently expanded the trial to 200 patients.
I share your enthusiasm about the Brilacidin for Covid-19 clinical trial. Hopefully the unique combination of being virucidal, anti-inflammatory as well as a broad spectrum antibiotic will prove efficacious in these sick patients.
It is possible the first 3 days will eliminate the virus while days 4 and 5 will prevent the immunologic over reaction which causes so many of the complications of Covid 19. Regardless of whether Brilacidin is given 3 or 5 days, it's long half life will extend its pharmacologic benefit.
We already know the current standard of care is inadequate for Covid19, I am expecting the robust preclinical in vitro RBL results will extend to the clinical trial. We will know for sure soon.
GLTA,Farrell
I share your enthusiasm about the Brilacidin for Covid-19 clinical trial. Hopefully the unique combination of being virucidal, anti-inflammatory as well as a broad spectrum antibiotic will prove efficacious in these sick patients.
It is possible the first 3 days will eliminate the virus while days 4 and 5 will prevent the immunologic over reaction which causes so many of the complications of Covid 19. Regardless of whether Brilacidin is given 3 or 5 days, it's long half life will extend its pharmacologic benefit.
We already know the current standard of care is inadequate for Covid19, I am expecting the robust preclinical in vitro RBL results will extend to the clinical trial. We will know for sure soon.
GLTA,Farrell
(10)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼